Latest news with #NationalBreastCancerFoundation
West Australian
06-08-2025
- Health
- West Australian
Ambitious project aims to stop breast cancer recurring
An ambitious goal to halve the number of deaths from breast cancer could be one step closer after a landmark investment in a medical research program. The National Breast Cancer Foundation has awarded a $25 million grant to researchers at the Garvan Institute of Medical Research in Sydney. The grant will fund the "AllClear" program, a research project focused on stopping recurrence of breast cancer, led by Garvan Institute Associate Professor Christine Chaffer. It will be vitally important for patients such as Amy Busdon, a mother of three girls, who was diagnosed in early 2024 just before her 40th birthday. With no family history, she was shocked when, the same week she was diagnosed, her mum called to tell her she too had breast cancer and would be undergoing treatment. "(The diagnosis) is just shattering in an instant," Ms Busdon said. "Everything just flashes before you. You think of the girls and your husband and start planning their life without you in it." In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. For some survivors, the breast cancer cells hide quietly in the body, commonly in the bone, and can reappear years or decades after the initial treatment. About 15 per cent of people will experience a cancer recurrence, which can often be life threatening. "We want to understand these cells and improve how we can find them because they are the ones we need to eradicate to stop recurrence and prevent patients from metastasis which can be really hard to treat," Prof Chaffer told AAP. "The research will also help us to understand what makes those cells different and work on treatments to eradicate dormant cells." The AllClear team will study cancer cells in the bone to understand how they hide, how they are different to cells in the primary tumour and why current treatments may fail. The research will help develop new therapies and fast-track their testing through clinical trials. Patients who have faced and treated a breast cancer diagnosis cannot currently be told whether their cancer is likely to recur, which Prof Chaffer said could cause enormous stress. "The fear of recurrence is huge and patients are living with that after cancer diagnosis - you can't underestimate the detrimental side effects of that fear," she said. For Ms Busdon, it's something she thinks about every day. "I've got three beautiful girls and I want to make sure I'm here for them when they grow up," she said. "Breast cancer research is so important and it gives me a lot of hope." The Garvan Institute research program aims to help patients know if they are "all clear" of cancer cells which could recur. "Being able to predict that will be a world a first," Prof Chaffer said. Australia's leading not-for-profit organisation which funds breast cancer research, NBCF has the ambitious goal of zero deaths from the disease. The death rate from breast cancer in Australia had reduced by 40 per cent in the past three decades which showed the needle could be moved, NBCF chief executive Cleola Anderiesz said. "We didn't improve this rate simply by good luck. It's been because of significant investment in research," Dr Anderiesz said. "The NBCF is completely community funded and our ability to invest in this extraordinary research is due to the generosity of our supporters."
Perth Now
06-08-2025
- Health
- Perth Now
Ambitious project aims to stop breast cancer recurring
An ambitious goal to halve the number of deaths from breast cancer could be one step closer after a landmark investment in a medical research program. The National Breast Cancer Foundation has awarded a $25 million grant to researchers at the Garvan Institute of Medical Research in Sydney. The grant will fund the "AllClear" program, a research project focused on stopping recurrence of breast cancer, led by Garvan Institute Associate Professor Christine Chaffer. It will be vitally important for patients such as Amy Busdon, a mother of three girls, who was diagnosed in early 2024 just before her 40th birthday. With no family history, she was shocked when, the same week she was diagnosed, her mum called to tell her she too had breast cancer and would be undergoing treatment. "(The diagnosis) is just shattering in an instant," Ms Busdon said. "Everything just flashes before you. You think of the girls and your husband and start planning their life without you in it." In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. For some survivors, the breast cancer cells hide quietly in the body, commonly in the bone, and can reappear years or decades after the initial treatment. About 15 per cent of people will experience a cancer recurrence, which can often be life threatening. "We want to understand these cells and improve how we can find them because they are the ones we need to eradicate to stop recurrence and prevent patients from metastasis which can be really hard to treat," Prof Chaffer told AAP. "The research will also help us to understand what makes those cells different and work on treatments to eradicate dormant cells." The AllClear team will study cancer cells in the bone to understand how they hide, how they are different to cells in the primary tumour and why current treatments may fail. The research will help develop new therapies and fast-track their testing through clinical trials. Patients who have faced and treated a breast cancer diagnosis cannot currently be told whether their cancer is likely to recur, which Prof Chaffer said could cause enormous stress. "The fear of recurrence is huge and patients are living with that after cancer diagnosis - you can't underestimate the detrimental side effects of that fear," she said. For Ms Busdon, it's something she thinks about every day. "I've got three beautiful girls and I want to make sure I'm here for them when they grow up," she said. "Breast cancer research is so important and it gives me a lot of hope." The Garvan Institute research program aims to help patients know if they are "all clear" of cancer cells which could recur. "Being able to predict that will be a world a first," Prof Chaffer said. Australia's leading not-for-profit organisation which funds breast cancer research, NBCF has the ambitious goal of zero deaths from the disease. The death rate from breast cancer in Australia had reduced by 40 per cent in the past three decades which showed the needle could be moved, NBCF chief executive Cleola Anderiesz said. "We didn't improve this rate simply by good luck. It's been because of significant investment in research," Dr Anderiesz said. "The NBCF is completely community funded and our ability to invest in this extraordinary research is due to the generosity of our supporters."
7NEWS
11-07-2025
- Entertainment
- 7NEWS
ghd's pink campaign is back to support breast cancer research — plus, win a hair tool at their Bondi Beach pop-up this weekend
The iconic ghd pink campaign is back for its 22nd year, and this time, it's pinker, prettier and more powerful than ever. Known globally for championing breast cancer awareness and raising more than $25 million for charities across the world, ghd's 2025 Pink Sorbet collection is more than just a hair tool launch; it's a statement. In partnership with the National Breast Cancer Foundation, $20 from every limited-edition Pink Sorbet purchase will go directly towards vital breast cancer research here in Australia. The limited-edition release includes some of ghd's bestselling stylers, dryers and brushes in a soft sorbet pink that looks just as good on your bathroom shelf as it does in action. Whether you're replacing your old styler or treating yourself to a next-gen multitasker, it's worth knowing that 2.3 million women are diagnosed with breast cancer globally each year. While hair and breasts are often tied to identity and femininity, breast cancer can take them both. ghd's campaign aims to restore confidence and power to women everywhere, with or without hair, through consistent education, empowerment and funding. The 2025 ghd Pink Sorbet collection includes: ghd chronos hair straightener, $465 ghd duet blowdry hair dryer brush, $595 ghd duet style hot air styler, $595 ghd gold hair straightener, $350 ghd glide hair straightening brush, $285 Each limited-edition product features the soft Pink Sorbet colourway, with professional-grade performance and that signature ghd sleek, polished finish. But it's not just about the launch, it's also about the vibe. This weekend, ghd is bringing the Euro Summer fantasy straight to Bondi Beach for a one-of-a-kind pop-up event that's part beauty, part Italian holiday, part charity celebration. Here's what's happening at the ghd pop-up at Da Orazio, Bondi: Free takeaway vodka pasta from Da Orazio (yes, ghd tagliatelle is a thing). Classic Italian sodas from Santa Vittoria. DJ sets to soundtrack your glam. Interactive curl styling with the new Chronos Curve range (four professional tongs and wands). Free photo booth prints to capture your curls. A chance to win your very own ghd wand or tong. And the first 50 arrivals each day will take home a free goodie bag worth over $190, packed with treats from Rare Beauty, Summer Fridays and Byoma. When: Saturday 12th and Sunday 13th July, 12pm to 3pm Where: Da Orazio, The Hub, Boheme, Bondi Beach Whether you're hunting for a new styler, a sunny weekend plan, or just a solid excuse to eat free carbs and get your hair done, the ghd Euro Summer pop-up has you covered. And with every limited-edition purchase of the pink collection, you're not just investing in great hair. You're helping fund breast cancer research and supporting thousands of women in the process.
Yahoo
04-06-2025
- Entertainment
- Yahoo
Jessie J diagnosed with early breast cancer, says she'll undergo surgery
Jessie J was diagnosed with "early breast cancer," the U.K. pop singer said on social media on Wednesday. The 37-year-old artist, whose real name is Jessica Ellen Cornish, said she was diagnosed with breast cancer before her latest single "No Secrets" was released in April. She said she will undergo surgery following her performance at Summertime Ball on June 15, an annual music festival in London. "Cancer sucks in any form, but I'm holding onto the word 'early'," she told her nearly 14 million followers on Instagram in a video. Jessie J said she's sharing her diagnosis partly because she's "not processing it," since she has been consumed with work. "Sharing in the past has helped me with other people giving me their love and support and also their own stories," the singer said. The video was met with a flurry of supportive comments, including from fellow British pop stars Rita Ora and Leigh-Anne Pinnock. "Your literally my favourite person and I'm praying for you you've got this. my mother had it and I know the surgery and any treatment on this matter is mentally tough so I'm here for you. X," Ora wrote. The Grammy-nominated signer is known for her powerful and unique vocal. Her greatest hits include "Price Tag," "Masterpiece," Do It Like a Dude," "Domino" and "Bang Bang," the 2014 collaboration with Ariana Grande and Nicki Minaj. Prior to "No Secrets," she had not release any new music since 2018. Breast cancer is characterized by five major stages, from Stage 0 to Stage 4. While the singer didn't disclose further details about her diagnosis, an early stage of breast cancer is "highly treatable and survivable," according to the National Breast Cancer Foundation. Sneak peek: Where is Jermain Charlo? Baldwin grills McMahon on unallocated funds for students, schools, approved by Congress Hegseth orders Navy to rename USNS Harvey Milk, Jeffries calls it "a complete and total disgrace"
CBS News
04-06-2025
- Entertainment
- CBS News
Jessie J diagnosed with "early breast cancer," says she'll undergo surgery after London music festival
Jessie J was diagnosed with "early breast cancer," the U.K. pop singer said on social media on Wednesday. The 37-year-old artist, whose real name is Jessica Ellen Cornish, said she was diagnosed with breast cancer before her latest single "No Secrets" was released in April. She said she will undergo surgery following her performance at Summertime Ball on June 15, an annual music festival in London. "Cancer sucks in any form, but I'm holding onto the word 'early'," she told her nearly 14 million followers on Instagram in a video. Jessie J said she's sharing her diagnosis partly because she's "not processing it," since she has been consumed with work. "Sharing in the past has helped me with other people giving me their love and support and also their own stories," the singer said. The video was met with a flurry of supportive comments, including from fellow British pop stars Rita Ora and Leigh-Anne Pinnock. "Your literally my favourite person and I'm praying for you you've got this. my mother had it and I know the surgery and any treatment on this matter is mentally tough so I'm here for you. X," Ora wrote. The Grammy-nominated signer is known for her powerful and unique vocal. Her greatest hits include "Price Tag," "Masterpiece," Do It Like a Dude," "Domino" and "Bang Bang," the 2014 collaboration with Ariana Grande and Nicki Minaj. Prior to "No Secrets," she had not release any new music since 2018. Breast cancer is characterized by five major stages, from Stage 0 to Stage 4. While the singer didn't disclose further details about her diagnosis, an early stage of breast cancer is "highly treatable and survivable," according to the National Breast Cancer Foundation.
